During the outbreak of COVID-19 period, in order to guarantee the urgent supply of nucleic acid extraction equipment for virus gene screening, our genetic testing team worked overtime quietly participating in the battle against the epidemic by sending AE2100 equipment to the front line of epidemic prevention, making due contributions to the victory of the "war on the epidemic". Our TCM granule equipment provides patients with TCM formula particles effectively and efficiently, making a significant contributions to fighting against this epidemic. At the beginning of 2020, Hollycon’s TCM granule dispensing equipment and Nucleic acid extraction equipment were selected to the and .

HollyCon has successfully combined the development direction advocated by our country with two business of Chinese Traditional Medicine and Genetic Testing run by our company, provided independent innovative products and platforms, and made contributions to the the country's major scientific and technological achievements in the field of life safety and biosafety. In the future, HollyCon will adhere to the implementation of the strategic concept of "Proprietary and controllable technology, Safe and reliable products", and continue to research and innovate core technologies in the field of traditional Chinese medicine and life science, and constantly introduce safe and practical products and solutions for the industry. HollyCon will fight for the purpose of realizing the automation and modernization of traditional Chinese medicine and help traditional Chinese medicine to be internationally recognized; and fight for the purpose of filling the gaps of autonomous and controllable high-end gene detection intelligent equipment in life science filed.